In a first for adults in Singapore, scientists are conducting gene editing trials on heart patients to correct defects at ...
A mission to search for the origin-of-life on Titan, Saturn's largest moon, will be aided by University of Otago – Ōtākou ...
Recognized in the Biotechnology category of the 2025 Top Innovations contest, small Cas12l nucleases are versatile, ...
A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.
Pairwise has licensed its Fulcrum® gene editing platform to the International Rice Research Institute (IRRI), a non-profit agricultural research organization. The agreement will enable IRRI to apply ...
A lthough still in its early days, CRISPR has already been called the most powerful scientific tool of the century. Using ...
A research team has successfully engineered a japonica rice variety using CRISPR/Cas9 to simultaneously optimize plant ...
CRISPR ETFs invest in companies perfecting gene-editing technology, potentially key for future disease treatments. Top CRISPR ETFs include ARK Genomic Revolution, Global X Genomics, and WisdomTree ...
A team of Chinese scientists has uncovered a hidden 3D structure in rice DNA that allows the crop to grow more grain while ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback